Compound ID | 471
Class: Dihydrofolate reductase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Dihydrofolate reductase inhibitor; trimethoprim resistant S. aureus |
| Description: | Trimethoprim derivative |
| Institute where first reported: | Hoffmann-La Roche Inc, Switzerland |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |